Assessing patients' descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: Results of qualitative research

International Journal of Clinical Practice

Volumn 64, Issue 9, 2010, Pages 1260-1278

  Coyne, K S ^a   Sexton, C C ^a   Kopp, Z ^b   Chapple, C R ^c   Kaplan, S A ^d   Aiyer, L P ^b   Symonds, T ^e  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b PFIZER INC   (United States)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^d NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^e PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLADDER; CYSTALGIA; DYSURIA; ERECTILE DYSFUNCTION; EXPECTATION; FEMALE; HUMAN; INFORMATION PROCESSING; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; QUALITATIVE RESEARCH; TREATMENT OUTCOME; UNITED STATES; UROLOGY;

ADULT; AGED; ATTITUDE TO HEALTH; FEMALE; FOCUS GROUPS; HUMANS; MALE; MIDDLE AGED; PROSTATISM; TERMINOLOGY AS TOPIC; TREATMENT OUTCOME; URINATION DISORDERS;

EID: 77954626363     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02450.x     Document Type: Article

References (19)

1. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003 61 : 37 49.
2. EMEA, Committee for Proprietary Medicinal Products. Reflection Paper on the Regulatory Guidance for the Use of Health-Related Quality of Life (HRQL) Measures in the Evaluation of Medicinal Products.
3. FDA. Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims.
4. Patrick DL, Burke LB, Powers JH et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007 10 (Suppl. 2 S125 37.
5. Barry MJ, Fowler Jr. FJ, O'Leary MP et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992 148 : 1549 1557 discussion 64.
6. Barry MJ, Girman CJ, O'Leary MP et al. Using repeated measures of symptom score, uroflowmetry and prostate specific antigen in the clinical management of prostate disease. Benign Prostatic Hyperplasia Treatment Outcomes Study Group. J Urol 1995 153 : 99 103.
7. Barry MJ, Williford WO, Chang Y et al. Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol 1995 154 : 1770 1774.
8. Donovan JL, Abrams P, Peters TJ et al. The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol 1996 77 : 554 562.
9. Donovan JL, Brookes ST, de la Rosette JJ et al. The responsiveness of the ICSmale questionnaire to outcome: evidence from the ICS-'BPH' study. BJU Int 1999 83 : 243 248.
10. Jackson S, Donovan J, Brookes S et al. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol 1996 77 : 805 812.
11. Barry MJ, Williford WO, Fowler FJ Jr. et al. Filling and voiding symptoms in the American Urological Association symptom index: the value of their distinction in a Veterans Affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia. J Urol 2000 164 : 1559 1564.
12. Hald T, Nordling J, Andersen JT et al. A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol Suppl 1991 138 : 59 62.
13. Hansen BJ, Flyger H, Brasso K et al. Validation of the self-administered Danish Prostatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperplasia. Br J Urol 1995 76 : 451 458.
14. Glover L, Gannon K, McLoughlin J, Emberton M. Men's experiences of having lower urinary tract symptoms: factors relating to bother. BJU Int. 2004 94 : 563 567.
15. Gannon K, Glover L, O'Neill M, Emberton M. Men and chronic illness: a qualitative study of LUTS. J Health Psychol. 2004 9 : 411 420.
16. Wareing M. Lower urinary tract symptoms: a hermeneutic phenomenological study into men's lived experience. J Clin Nurs 2005 14 : 239 246.
17. Kinchen KS, Burgio K, Diokno AC et al. Factors associated with women's decisions to seek treatment for urinary incontinence. J Womens Health (Larchmt) 2003 12 : 687 698.
18. Hagglund D, Ahlstrom G. The meaning of women's experience of living with long-term urinary incontinence is powerlessness. J Clin Nurs 2007 16 : 1946 1954.
19. DuBeau CE, Levy B, Mangione CM, Resnick NM. The impact of urge urinary incontinence on quality of life: importance of patients' perspective and explanatory style. J Am Geriatr Soc 1998 46 : 683 692. (Pubitemid 128722273)